TREATMENT OF RHEUMATIC DISEASES INTERRELATION OF SELECTIVE NON-STEROIDAL ANTIINFLAMMATORY DRUG CELEBREX (CELECOXIB) AND INHIBITOR OF ENZYME WITH APF ENAP (ENALAPR1L) IN PATIENTS WITH RHEUMATIC DISEASES AND CONCOMITANT ARTERIAL HYPERTENSION
Objective. To assess the effect of selective NSAID Celecoxib on the indices of arterial pressure in RD pts with concomitant arterial hypertension and taking Enalapril. Material and methods. 10 pts (5-RA, 5 - OA) had daily monitoring of arterial pressure, assessment of renal functions against backgro...
Saved in:
| Main Authors: | Yu. V. Mouraviev, T N Tsapina, L N Kashnikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2002-06-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1124 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Celecoxib in rheumatic diseases: possibilities and prospects. Brief descriptive survey
by: A. E. Karateev
Published: (2024-10-01) -
To the 100th anniversary of the birth of academician V.A. Nasonova. Pain control in rheumatic diseases: Past and future
by: A. E. Karateev
Published: (2023-04-01) -
CARDIOVASCULAR EFFECTS OF SELECTIVE COX-2 INHIBITORS IN RHEUMATIC DISEASES
by: Rimma Mikhailovna Balabanova
Published: (2010-06-01) -
<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
by: V. T. Ivashkin, et al.
Published: (2012-11-01) -
Activation of monocytes and early manifestations of cardiovascular diseases in patients with immuneinflammatory rheumatic diseases
by: M. V. Shalygina
Published: (2025-03-01)